MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized holding gain
(loss)
$1,724K
Total comprehensive
loss
-$274,755K
Total other
comprehensive income (loss)
$1,724K
Interest income
$27,035K
Net loss
-$276,479K
Total other income,
net
$26,259K
License and other
revenue
$15,355K
Other (expense)
income
-$776K
Loss from operations
-$302,738K
Total revenue
$15,355K
Total operating
expenses
$318,093K
Research and development
expenses
$261,383K
General and
administrative expenses
$56,710K
Back
Back
Income Statement
source: myfinsight.com
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)